CAS 2169-98-4

1-(3,4-dimethoxyphenyl)-N-hydroxymethanimine

Description:

1-(3,4-Dimethoxyphenyl)-N-hydroxymethanimine, with the CAS number 2169-98-4, is an organic compound characterized by its unique structure, which includes a hydroxymethanimine functional group attached to a dimethoxy-substituted phenyl ring. This compound typically exhibits properties associated with both aromatic and amine functionalities, such as potential reactivity in nucleophilic addition reactions due to the presence of the hydroxymethanimine moiety. The dimethoxy groups contribute to the compound's electron-donating characteristics, which can influence its reactivity and stability. In terms of solubility, compounds of this nature are often soluble in organic solvents, while their solubility in water may vary depending on the specific functional groups present. The presence of the hydroxyl group can also impart some degree of polarity. Additionally, this compound may exhibit biological activity, making it of interest in medicinal chemistry and pharmacology. However, specific applications and biological effects would require further investigation and research.

Formula: C₉H₁₁NO₃

InChI: InChI=1/C9H11NO3/c1-12-8-4-3-7(6-10-11)5-9(8)13-2/h3-6,11H,1-2H3

InChI key: InChIKey=LHZIVRAMZJJLAP-UHFFFAOYSA-N

SMILES: O(C)C1=C(OC)C=CC(C=NO)=C1

Synonyms:

• Veratraldehyde, oxime
• 3,4-Dimethoxybenzaldoxime
• Veratraldoxime
• 3,4-Dimethoxybenzaldehyde oxime
• Benzaldehyde, 3,4-dimethoxy-, oxime
• (1E)-3,4-dimethoxybenzaldehyde oxime
• 3,4-Dimethoxy-benzaldoxim
• Nsc27025

3,4-Dimethoxybenzaldehyde oxime

CAS: 2169-98-4

Formula: C₉H₁₁NO₃

Purity: 98.0%

Color and Shape: Solid

Molecular weight: 181.191

Ref: 10-F047113

Veratraldoxime

CAS: 2169-98-4

Veratraldoxime is a synthetic compound that is the diacetate ester of oxime and has been used in the treatment of inflammatory bowel disease. It has been shown to be effective in some patients, but not all, with ulcerative colitis. Veratraldoxime inhibits the production of inflammatory mediators by inhibiting the activity of cyclooxygenase-2 and lipoxygenase. This drug also has anti-inflammatory properties by inhibiting prostaglandin synthesis at the level of phospholipase A2 and cyclooxygenase-1. The mechanism of action for this drug is similar to that of other nonsteroidal anti-inflammatory drugs (NSAIDs). Veratraldoxime also inhibits protein synthesis by blocking the formation of amide bonds, thereby inhibiting bacterial growth. The oxidation products are responsible for its antibiotic properties. Veratraldoxime binds to copper chromite to form a coordination complex, which is

Formula: C₉H₁₁NO₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 181.19 g/mol

Ref: 3D-FV67644